Skip to content

DXR

Daxor Corporation

NASDAQ · Healthcare · Medical - Instruments & Supplies · US

$10.27
−2.66%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue868.5K503.4K2.1M34.6M(353.4K)
Cost of Revenue394.5K314.7K177.1K1.1M
Gross Profit474.0K188.7K2.1M34.4M(1.4M)
Operating Expenses
R&D Expense(14.65)
SG&A Expense1.5M294.2K307.4K1.1M
General & Admin Expense283.2K294.2K307.4K1.1M
Selling & Marketing Expense1.2M
Other Expenses(6.3M)(9.0M)1.3M631.7K14.65
Total Operating Expenses(4.9M)(9.0M)1.6M939.1K1.1M
Cost and Expenses(7.3M)(8.7M)1.6M34.3M(5.6M)
Operating Income (EBIT)8.2M9.2M621.4K329.7K5.3M
Non-Operating
Interest Income41.1K26.7K
Interest Expense16.0K16.0K85.1K49.1K72.5K
Net Interest Income25.2K10.7K(85.1K)(49.1K)(72.5K)
Other Non-Op Income/Expense(141.7K)(16.0K)(85.1K)(49.1K)(72.5K)
Non-Operating Income (excl Interest)20.9K
EBT (Pre-Tax Income)8.0M9.2M536.3K280.6K5.2M
Income Tax Expense
Bottom Line
Net Income8.0M9.2M536.3K280.6K5.2M
Earnings from Cont. Ops8.0M9.2M536.3K280.6K5.2M
Earnings from Discont. Ops
Bottom Line Net Income8.0M9.2M536.3K280.6K5.2M
Per Share
Basic EPS$1.60$1.84$0.11$0.06$0.60
Diluted EPS$1.60$1.84$0.11$0.06$0.60
Revenue Per Share$0.17$0.10$0.44$7.47($0.04)
Shares
Basic Shares Outstanding5.0M5.0M4.8M4.6M8.6M
Diluted Shares Outstanding5.0M5.0M4.8M4.6M8.6M
Profitability Metrics
EBITDA9.6M9.2M2.1M329.7K6.1M
D&A1.4M1.4M506.8K859.7K
EBIT8.2M9.2M621.4K329.7K5.3M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026